National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 51851-51852 [2017-24267]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
Contact Person: Chee Lim, Ph.D., Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 4128,
Bethesda, MD 20892, 301–435–1850, limc4@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 2, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–24262 Filed 11–7–17; 8:45 am]
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
ethrower on DSK3G9T082PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Asthma
Education Prevention Program
Coordinating Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Asthma
Education Prevention Program Coordinating
Committee.
Date: December 14, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: Welcome and committee charge.
Place: National Institutes of Health, 6701
Rockledge Drive, Suite 10018, Bethesda, MD
20892 (Virtual Meeting-Webinar).
Contact Person: James P. Kiley, Ph.D.,
Director, Division of Lung Diseases, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6701 Rockledge Drive,
Suite 10018, Bethesda, MD 20892–7952, 301–
435–0233, kileyj@nhlbi.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/health-pro/resources/
lung/naci/asthma-info/naepp.htm, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Jkt 244001
[FR Doc. 2017–24265 Filed 11–7–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute: Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:26 Nov 07, 2017
Dated: November 2, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NHLBI Special Emphasis
Panel.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI TOPMed Data Analysis.
Date: December 1, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7182, Bethesda, MD 20892,
(301) 827–7987, susan.sunnarborg@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 2, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–24266 Filed 11–7–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
51851
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity Research.
Date: November 27, 2017
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542 (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK P01–A1
Review.
Date: December 1, 2017.
Time: 9:50 a.m. to 11:50 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452 (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK RC2 Review.
Date: December 5, 2017.
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
E:\FR\FM\08NON1.SGM
08NON1
51852
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452 (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Personalized
Biofeedback to Enhance Performance
Training in Elite Athletes Using Exhaled
Breath 13CO2/12CO2 as a Metabolic Marker.
Date: December 11, 2017.
Time: 1:00 p.m. to 2:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452 (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK SBIR Phase
II Exploratory Clinical Trials.
Date: December 15, 2017.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7021, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452 (301) 594–3993,
tathamt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 2, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–24267 Filed 11–7–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ethrower on DSK3G9T082PROD with NOTICES
Center for Scientific Review: Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
November 8, 2017, 2:00 p.m. to
November 8, 2017, 4:00 p.m., National
Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD, 20892 which was
VerDate Sep<11>2014
17:26 Nov 07, 2017
Jkt 244001
published in the Federal Register on
October 18, 2017, 82 FR 48522–48523.
The meeting will be held on
November 7, 2017. The meeting time
and location remain the same. The
meeting is closed to the public.
Dated: November 2, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–24264 Filed 11–7–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Automated Commercial Environment
(ACE) Becoming the Sole CBPAuthorized Electronic Data
Interchange (EDI) System for
Generating, Transmitting and Updating
Daily and Monthly Statements
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document announces
that the Automated Commercial
Environment (ACE) will be the sole
electronic data interchange (EDI) system
authorized by U.S. Customs and Border
Protection (CBP) for generating,
transmitting, and updating daily and
monthly statements for all entries
except reconciliation (type 09) entries.
This document also announces that the
Automated Commercial System (ACS)
will no longer be a CBP-authorized EDI
system for processing such statements.
DATES: As of December 9, 2017, ACE
will be the sole CBP-authorized EDI
system for generating, transmitting, and
updating daily and monthly statements,
and ACS will no longer be a CBPauthorized EDI system for such purpose.
FOR FURTHER INFORMATION CONTACT: For
policy-related questions, contact Randy
Mitchell, Commercial Operations,
Revenue and Entry, Trade Policy and
Programs, Office of Trade, via email at
otentrysummary@cbp.dhs.gov. For
technical questions, contact Celestine
Harrell, Revenue Modernization Branch,
Trade Transformation Office, Office of
Trade, via email at Celestine.Harrell@
cbp.dhs.gov with a subject line
identifier reading ‘‘Statement Processing
in ACE’’.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Section 484 of the Tariff Act of 1930,
as amended (19 U.S.C. 1484),
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
establishes the requirement for
importers of record to make entry for
merchandise to be imported into the
customs territory of the United States.
Customs entry information is used by
U.S. Customs and Border Protection
(CBP) and Partner Government Agencies
(PGAs) to determine whether
merchandise may be released from CBP
custody. Importers of record are also
obligated to complete the entry by filing
an entry summary declaring the value,
classification and rate of duty applicable
to the merchandise and such other
information as is necessary for CBP to
properly assess duties, collect accurate
statistics and determine whether any
other applicable requirement of law is
met. See 19 U.S.C. 1484(a)(1)(B).
Section 505 of the Tariff Act of 1930,
as amended (19 U.S.C. 1505),
establishes the requirement for
importers of record to deposit with CBP
the amount of duties and fees estimated
to be payable on merchandise unless
that merchandise is entered for
warehouse or transportation, or under
bond. According to section 141.101 of
Title 19 of the Code of Federal
Regulations (CFR), estimated duties
shall either be deposited with a CBP
officer at the time of filing of entry or
entry summary documentation, or be
transmitted to CBP pursuant to the
statement processing method.
A. Statement Processing
Statement processing is a voluntary
automated program for participants in
the Automated Broker Interface (ABI)
which allows entries to be grouped on
a daily basis by importer or filer, and
allows payment of related duties, fees
and taxes by a single payment. See 19
CFR 24.1(a)(8) and 24.25 and 143.32(p).
The preferred method of payment for
users of statement processing is by
Automated Clearinghouse (ACH). See 19
CFR 24.25(a). According to 19 CFR
143.32(p), ACS, or any other CBPauthorized EDI system, generates the
statement, which is transmitted
electronically to the filer, consisting of
a list of entry summaries and the
amount of duties, fees and taxes due for
payment. Currently, the daily
statements are generated, transmitted
and updated in ACS.
B. Periodic Monthly Statement Test
Program
As an alternative to paying ACH
statements on a daily basis, participants
in the periodic monthly statements
(PMS) test may pay ACH statements on
a monthly basis. CBP announced its
plan to conduct the PMS test on
February 4, 2004 in a notice in the
Federal Register (69 FR 5362) which
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 82, Number 215 (Wednesday, November 8, 2017)]
[Notices]
[Pages 51851-51852]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24267]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity
Research.
Date: November 27, 2017
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542 (301)
594-8898, barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK P01-A1 Review.
Date: December 1, 2017.
Time: 9:50 a.m. to 11:50 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301)
594-4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK RC2 Review.
Date: December 5, 2017.
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
[[Page 51852]]
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301)
594-4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Personalized Biofeedback
to Enhance Performance Training in Elite Athletes Using Exhaled
Breath 13CO2/12CO2 as a Metabolic Marker.
Date: December 11, 2017.
Time: 1:00 p.m. to 2:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Paul A. Rushing, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301)
594-8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK SBIR Phase II
Exploratory Clinical Trials.
Date: December 15, 2017.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Thomas A. Tatham, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301)
594-3993, tathamt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: November 2, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-24267 Filed 11-7-17; 8:45 am]
BILLING CODE 4140-01-P
